Arkolith/Insider Trading/ERNA/Form 4

Cherington Charles

Director, 10% OwnerEterna Therapeutics Inc. (ERNA) · full profile →Form 4 · filed Dec 6, 2022
Net Buying
Open-Market Buys
$859K
Open-Market Sells
$0
Net Open-Market Flow
$859K
Transactions
2
1 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Dec 2, 2022Buy(P)262K$3.28$859K556K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Dec 2, 2022Buy(P)524K$0.13$68K524K

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001140361-22-044639) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML